Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.
Press releases published on June 12, 2025
NordPass aims to solve the password sharing mess in companies with a new feature
GlobeNewswire
·
June 12, 2025
LONDON, June 12, 2025 (GLOBE NEWSWIRE) -- NordPass, a password manager and innovator of seamless authentication solutions, has introduced a unique, user-friendly dashboard that gives businesses control over all their shared credentials and folders. This …
Werewolf Therapeutics to Participate in the BIO International Convention
GlobeNewswire
·
June 12, 2025
WATERTOWN, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …
BairesDev Ranked Among Clutch’s Top Software Leaders 2025 with Triple Recognition
GlobeNewswire
·
June 12, 2025
MOUNTAIN VIEW, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- BairesDev®, an award-winning nearshore software development company, has been recognized with three 2025 Clutch Awards, highlighting its performance and reliability in software development across key …
Rackspace Study Reveals AI Leaders Are Scaling Agents at 3x the Rate of Their Peers
GlobeNewswire
·
June 12, 2025
SAN ANTONIO, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology (NASDAQ: RXT), a leading hybrid cloud and AI solutions company, today released a global report, The AI Acceleration Gap: Why Some Enterprises are Surging Ahead, revealing a widening …
BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients
GlobeNewswire
·
June 12, 2025
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the …
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
GlobeNewswire
·
June 12, 2025
Key complex product approval in the Affordable Medicines segment this year Commercial launch planned for third quarter of 2025 BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the …
AIM ImmunoTech Announces NYSE American Removal of Trading Suspension
GlobeNewswire
·
June 12, 2025
OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) (“AIM” or the “Company”) today announced that the staff of NYSE Regulation has withdrawn its delisting determination and will be lifting the trading …
CLEAR and Greenhouse Announce Partnership to Enable Candidate Verification
GlobeNewswire
·
June 12, 2025
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced a new partnership with Greenhouse, trusted HR tech leader and hiring platform, to implement CLEAR1, the identity platform for businesses, to improve …
Rezolve Ai Locks In $70 Million ARR Months Ahead of Plan; Now on Track to Exceed $100 Million ARR by Year-End
GlobeNewswire
·
June 12, 2025
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, today announced that it has secured more than $70 million in Annual Recurring Revenue (ARR) months ahead …
Rgenta Therapeutics Presents Preclinical Data from Lead Program, RGT-61159, a Potent and Selective Small Molecule Inhibitor of MYB RNA, Supporting its Application in the Treatment of Acute Myeloid Leukemia (AML)
GlobeNewswire
·
June 12, 2025
WOBURN, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, …
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
GlobeNewswire
·
June 12, 2025
Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third …
Richtech Robotics’ Titan Selected as Robotics Innovation of the Year by the SupplyTech Breakthrough Awards
GlobeNewswire
·
June 12, 2025
Las Vegas, NV, June 12, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a Nevada-based provider of AI-driven service robots, announced that its Titan robot was selected as the winner of the Robotics …
illumin Announces Voting Results of Annual Meeting of Shareholders
GlobeNewswire
·
June 12, 2025
TORONTO and NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX:ILLM, OTCQB:ILLMF) (“illumin” or “Corporation”), the advertising technology platform that enables you to win your next customer, today announced that at its annual general …
XRP Mining: It is expected that the proportion of cryptocurrency holdings in the UK will exceed that of the United States in 2025, and cloud mining will become the first choice for investors
GlobeNewswire
·
June 12, 2025
London, UK , June 12, 2025 (GLOBE NEWSWIRE) -- According to data reports, the UK has been rising rapidly in the past two years and has become the world's leading cryptocurrency holder. As of April 2025, 24% of adults surveyed in the UK hold …
SoarFun Launches New Era of Web3 Interaction with Gatrifi: A Gamified, Transparent Platform for On-Chain Engagement
GlobeNewswire
·
June 12, 2025
Gibraltar, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- SoarFun, an emerging player at the intersection of blockchain and gaming, has officially introduced its next-generation platform built around the “Gatrifi” model — a novel fusion of gaming, …
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics
GlobeNewswire
·
June 12, 2025
Ra’anana, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a biotechnology company developing intranasal drug delivery systems, today announced encouraging preclinical results from a recent study …
Angitia Biopharmaceuticals Announces Topline Results from First in Human Study of AGA2115, A Bispecific Antibody for the Treatment of Osteogenesis Imperfecta
GlobeNewswire
·
June 12, 2025
WESTLAKE VILLAGE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced topline …
Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
GlobeNewswire
·
June 12, 2025
Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase 1b study of DISC-0974 in anemia of …
Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
GlobeNewswire
·
June 12, 2025
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and …
New Wave Announces Proposed Name Change and Reiterates Its Investment Policy
GlobeNewswire
·
June 12, 2025
Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it is proposing a name change and reiterates its Investment Policy and strategic focus. …